Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aaftin gel versus triamcinolone for aphthous ulcer
IRCT20180707040375N1Phase 3Completed
- Sponsor
- Sohrab sarhadi (myself)
- Start
- Sep 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of triamcinolone in aphthosis (RAS) (2 arms), sponsored by Sohrab sarhadi (myself). Primary endpoint: Primary efficacy endpoint. Started Sep 2018; status: completed.
02
Drugs
triamcinolone
03
Conditions
aphthosis (RAS)
Beyond the preview
Go deeper on IRCT20180707040375N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180707040375N1.